Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06649864 · ClinicalTrials.gov registry record · Phase 1
Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
A Phase 1 study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT06649864: Clinical Trial Phase 1 study, sponsored by Mayo Clinic.
NCT06649864 is a Phase 1 study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06649864, a Phase 1 study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety of autologous Adipose-Derived Mesenchymal Stem Cell for use in End-Stage Liver Disease patients undergoing the creation of a duct-to-duct anastomosis during Living Donor Liver Transplantation.
Primary Outcome
Number of subjects to experience systemic symptoms, irritation, inflammation, infections or biliary obstructions
Interventions
- DRUG Autologous adipose derived mesenchymal stromal cells (AMSC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2027-02 |
| Est. Completion | 2028-06 |
| Phase | Phase 1 |
What is known before NCT06649864 opens enrollment
NCT06649864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which Autologous adipose derived mesenchymal stromal cells (AMSC) is the first listed.
NCT06649864 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06649864 about?
NCT06649864 is a clinical study titled "Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications". The purpose of this study is to assess the safety of autologous Adipose-Derived Mesenchymal Stem Cell for use in End-Stage Liver Disease patients undergoing the creation of a duct-to-duct anastomosis during Living Donor Liver Transplantation.
What is the current status of trial NCT06649864?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2027-02. Estimated completion is 2028-06.
What interventions are being tested in trial NCT06649864?
The interventions under investigation include: Autologous adipose derived mesenchymal stromal cells (AMSC) (DRUG).
Who is sponsoring clinical trial NCT06649864?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06649864's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia